Cargando…
Le vaccin Sars-CoV-2 de Moderna : les résultats de l’essai-pivot de phase 3 en clair
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953717/ https://www.ncbi.nlm.nih.gov/pubmed/33747151 http://dx.doi.org/10.1016/S1773-035X(21)00051-4 |
| _version_ | 1783663970666676224 |
|---|---|
| author | Manus, Jean-Marie |
| author_facet | Manus, Jean-Marie |
| author_sort | Manus, Jean-Marie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7953717 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79537172021-03-15 Le vaccin Sars-CoV-2 de Moderna : les résultats de l’essai-pivot de phase 3 en clair Manus, Jean-Marie Rev Francoph Lab Article Elsevier Masson SAS. 2021-03 2021-03-12 /pmc/articles/PMC7953717/ /pubmed/33747151 http://dx.doi.org/10.1016/S1773-035X(21)00051-4 Text en Copyright © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Manus, Jean-Marie Le vaccin Sars-CoV-2 de Moderna : les résultats de l’essai-pivot de phase 3 en clair |
| title | Le vaccin Sars-CoV-2 de Moderna : les résultats de l’essai-pivot de phase 3 en clair |
| title_full | Le vaccin Sars-CoV-2 de Moderna : les résultats de l’essai-pivot de phase 3 en clair |
| title_fullStr | Le vaccin Sars-CoV-2 de Moderna : les résultats de l’essai-pivot de phase 3 en clair |
| title_full_unstemmed | Le vaccin Sars-CoV-2 de Moderna : les résultats de l’essai-pivot de phase 3 en clair |
| title_short | Le vaccin Sars-CoV-2 de Moderna : les résultats de l’essai-pivot de phase 3 en clair |
| title_sort | le vaccin sars-cov-2 de moderna : les résultats de l’essai-pivot de phase 3 en clair |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953717/ https://www.ncbi.nlm.nih.gov/pubmed/33747151 http://dx.doi.org/10.1016/S1773-035X(21)00051-4 |
| work_keys_str_mv | AT manusjeanmarie levaccinsarscov2demodernalesresultatsdelessaipivotdephase3enclair |